[Studies on the sensitivity of Actinomyces israeli and 2 of its most frequently associated anaerobic bacteria to new antibiotics (6-D-alpha-aminobenzylpenicillin, aminosidin, colistin, kanamycin, novobiocin, oleandomycin, spiramycin, vancomycin)].
D000190:Actinomyces / Q000187:drug effects*; D000667:Ampicillin / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D003091:Colistin / Q000494:pharmacology; D066298:In Vitro Techniques; D007612:Kanamycin / Q000494:pharmacology; D007933:Leucomycins / Q000494:pharmacology; D009675:Novobiocin / Q000494:pharmacology; D009827:Oleandomycin / Q000494:pharmacology; D010403:Penicillin Resistance; D014640:Vancomycin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D007933:Leucomycins; D009675:Novobiocin; D007612:Kanamycin; D014640:Vancomycin; D000667:Ampicillin; D009827:Oleandomycin; D003091:Colistin
Untersuchungen über die Empfindlichkeit des Actinomyces israeli und zwei seiner häufigsten anaeroben Begleitbakterien gegen neuere Antibiotica (6-D-alpha-Aminobenzylpenicillin, Aminosidin, Colistin, Kanamycin, Novobiocin, Oleandomycin, Spiramycin, Vancomycin)